jxdn (pronounced "Jaden") is an American singer-songwriter who rose to fame on TikTok before launching his music career in 2020. His debut single, "Comatose," became a hit and was followed by collaborations with artists like Iann Dior and a debut album, Tell Me About Tomorrow. Merging rock, pop-punk, and emo rap, jxdn's music appeals to fans of various genres. With a massive social following and new album When The Music Stops dropping on June 28th, 2024, jxdn is a rising star to keep an eye on.

On the episode of Going There with Dr. Mike, jxdn discusses the emotional pain that he has experienced including depression, anxiety, and feelings of emptiness throughout his life.

Listen to jxdn chat about all of this and more in the new episode of Going There with Dr. Mike. 

Learn more about JXDN here.

Then make sure to like, review, and subscribe to the show, presented by the Consequence Podcast Network and Sound Mind Live, wherever you get your podcasts.

Season 5 of Going There with Dr. Mike is brought to you by Johnson & Johnson who believes that health is everything. Their strength in healthcare innovation empowers them to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through their expertise in Innovative Medicine and MedTech, they are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at www.jnj.com @JanssenUS and @JNJInnovMed on Twitter.

This season is also brought to you by AbbVie, who is driving the pursuit of better mental health. Over the last 30 years, AbbVie’s scientists and clinicians have worked to tackle the complexity of mental illness and today offer a portfolio of medicines and a pipeline of innovation that spans depression, anxiety, bipolar 1 disorder, and schizophrenia. To learn more about AbbVie’s work to support individuals throughout their mental health journey, please visit www.AbbVie.com or follow at AbbVie on Twitter, Facebook, Instagram, YouTube, and LinkedIn.